Tevogen Bio Updates on EBV-Specific CTL Therapy Development and Collaboration with Tevogen.AI
18/6 14:42
Tevogen Bio is advancing CTL therapy for EBV-associated lymphomas, utilizing its ExacTcell™ technology and AI-driven peptide selection....
18/6 14:42
Tevogen Bio is advancing CTL therapy for EBV-associated lymphomas, utilizing its ExacTcell™ technology and AI-driven peptide selection....